Abstract:OBJECTIVE:To construct a recombinant adenovirus vector expressing TbetaR-II extracellular domain-RANTES fusion gene and evaluate its anti-tumor effects.METHODS:Mouse origin TbetaR-II extracellular domain and RANTES gene were amplified by RT-PCR. The TbetaR-II extracellular domain-RANTES fusion gene was amplified by overlapping PCR method. TbetaR-II extracellular domain-RANTES fusion gene was cloned into pDC316 vector. The recombinant adenovirus vector expressing the fusion gene was constructed by adMax adenovirus vector creation system. Recombinant adenovirus vector expressing the fusion gene was transfected into LA795 cells. The expression of recombinant adenovirus was checked by Westen blot. The levels of TGF-beta1, RANTES in supernatant were checked by ELISA. The transfected cells were counted and growth curve was obtained. Apoptosis of transfected cells was detected by Annexin V FITC method. The chemotactic activity of supernatant of transfected cells to splenic lymphocytes was assayed. Transfected cells (1 x 10(5)) were inoculated into T739 mice and to observe the tumor growth and survival time. Ad-TbetaR-II extracellular domain, Ad-RANTES and Ad-TbetaR-II extracellular domain-RANTES fusion gene(1 x 10(10) pfu) were injected into the tumor in T739 mice. The tumor size and tumor weight were recorded and tumor growth inhibition rate was counted and statistically analyzed.RESULTS:TbetaR-II extracellular domain and RANTES gene were amplified by RT-PCR and TbetaR-II extracellular domain-RANTES fusion gene amplified by overlapping PCR, were identified by DNA sequence analysis. Restriction enzyme digestion analysis showed that the recombinant vector was constructed correctly. The recombinant adenovirus vector expressing the fusion gene was constructed successfully using the AdMax Adenovirus Vector Creation System. Its titer was 8 x 10(10) pfu/ml. Ad-TbetaR-II extracellular domain-RANTES fusion gene was transfected into LA795 cells and had specific protein fragment proved by Western Blot. The concentration of TGF-beta1 was decreased and RANTES was increased in supernatant of transfected cells. The growth curve showed that recombinant adenovirus vector expressing the fusion gene could delay tumor development and induce apoptosis, with an apoptosis rate in vitro of 16.9%. The supernant of infected cells showed chemotactic activity to splenic lymphocytes. Tumor growth and survival time were prolonged significantly in group tranfected with recombinant adenovirus vector expressing the fusion gene, and tumor growth was effectively inhibited after injecting recombinant adenovirus vector expressing the fusion gene, with a tumor growth inhibition rate of 37.6%.CONCLUSION:A recombinant adenovirus vector expressing TbetaR-II extracellular domain-RANTES fusion gene has been constructed successfully. The recombinant adenovirus vector can bind TGF-beta1 effectively, counteract immune suppression mediated by TGF-beta, enhance immune function, induce significant antitumor immune respone, inhibit tumor growth, and prolong the survival time of tumor-bearing mice.

Construction and Expression of Recombinant Adenovirus Vector Encoding Human Somatostatin Receptor Type 2

Adenoviral-mediated Somatostatin Receptor Subtype 2 Gene Transfer Inhibits Pancreatic Cancer Xenografts

Inhibition of Metastatic Progression of SSTR2 Gene Transfection Mediated by Adenovirus in Human Pancreatic Carcinoma Cells

Gene Transfer of Somatostatin Receptor Type 2 by Intratumoral Injection Inhibits Established Pancreatic Carcinoma Xenografts

Anti-migratory and anti-invasive effect of somatostatin receptor type2 gene in human pancreatic carcinoma cell

Construction and evaluation of the eukaryotic expression plasmid encoding two copies of somatostatin genes fused with hepatitis B surface antigen gene S.

[Construction and Expression of the Eukaryotic Expression Vector Containing Human Soluble Transforming Growth Factor Beta Receptor II].

Anti-angiogenic effects of somatostatin receptor subtype 2 on human pancreatic cancer xenografts.

Antiangiogenic Effect of Somatostatin Receptor Subtype 2 on Pancreatic Cancer Cell Line: Inhibition of Vascular Endothelial Growth Factor and Matrix Metalloproteinase-2 Expressionin Vitro

Mechanisms of Inhibition of Growth of Human Pancreatic Carcinoma Implanted in Nude Mice by Somatostatin Receptor Subtype 2

[Mechanisms of Inhibition of Growth of Human Pancreatic Carcinoma Implanted in Nude Mice by Somatostatin Receptor Subtype 2].

[Construction of a Recombinant Adenoviral Vector Expressing Human Endostatin].

[Construction and Expression of Recombinant Adenovirus Expression Vector of Beta-Defensin-2].

[Construction of the Recombinant Adenovirus Vector Bearing Dual-Survivin Shrna].

Construction of Replication-Deficient Recombinant Adenovirus Carrying Vasostatin Gene and Its Inhibitory Effect on Pancreatic Cancer

Construction and Expression of Somatostatin DNA Vaccine pEGS/2SS in HeLa

Construction of eukaryotic expression vector containing HSV-TK and IL-2 double genes and its expression in human pulmonary adenocarcinoma cell A549.

Construction of Somatostatin Genetic Vaccine pcS/SS and Its Expression in HeLa Cells

Construction of recombinant adenovirus vector containing HBx gene and its expression in SMMC-7721 cell line

[Construction of Recombinant Adenovirus Vector Expressing Extracellular Domain of TbetaR-II-RANTES Fusion Gene and Its Anti-Tumor Effects].

Overexpression of SSTR2 inhibited the growth of SSTR2-positive tumors via multiple signaling pathways.